Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
The FDA has granted Fast Track Designation to Coherent Biopharma's CBP-1019 for treating recurrent endometrial cancer in patients who have received at least one platinum-based therapy.
Coherent Biopharma's CBP-1008 has been granted Fast Track Designation by the FDA for treating platinum-resistant ovarian clear cell carcinoma (OCCC).